Clinical trials: Immunocompromised Patients
Discitis
Unilateral Posterolateral Approach for Spondylodiskitis
This retrospective study assess the efficacy and safety of a posterolateral unilateral approach for debridement and titanium cage insertion supplemented by contralateral transfascial screw fixation for sick patients suffering…
- Trial name
- SPDTIS (NCT03472131)
- Testing
- Unilateral Posterolateral Approach and Debridement, Titanium cage insertion supplemented by screw fixation
- Volunteers
- 20 people
- Sponsor
- University Hospital of Patras
Candidiasis
Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units
This study will examine whether the anti-fungal drug caspofungin can prevent Candida infections in adult patients in intensive care units (ICUs).
- Trial name
- NCT00099775
- Testing
- Caspofungin
- Where
- United States
- Volunteers
- 1,200 people
- Sponsor
- National Cancer Institute (NCI)
Fungal Infection
Alternate Day Micafungin: A PK Study in Pediatric Patients
The purpose of this study is to examine the pharmacokinetics of micafungin when it is given on an every other day schedule. The study will determine if every other day micafungin will provide drug exposure equivalent to daily…
- Trial name
- NCT00842504
- Testing
- Micafungin
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Children's Hospital Medical Center, Cincinnati
COVID-19, Immunodeficiency
OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients
The overall purpose of the trial is to evaluate the efficacy and safety of possible combination antiviral therapy direct antiviral agents (remdesivir + nirmatrelvir/r) versus the reference monotherapy (nirmatrelvir/r alone) and…
- Trial name
- SWISS OPTICOV (NCT07406217)
- Testing
- Paxlovid 5 days, Paxlovid 10 days
- Where
- 4 sites in Switzerland
- Volunteers
- 256 people
- Sponsor
- Calmy Alexandra